At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,060 enrolled
Drug / intervention
Drug-specific alertother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Drug-Targeted Alerts for Acute Kidney Injury
In Brief
A clinical study evaluating Drug-specific alert for Acute Kidney Injury. Completed, enrolled 5,060 participants across 1 site.
Detailed Summary
In this trial, patients with acute kidney injury who have recently received a drug that may affect kidney function will be randomized to having an alert placed in the electronic health record or usual care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartAug 2020
Primary CompletionDec 2021
Study CompletionJan 2022
TodayJul 2026
First PostedMay 13, 2016
Enrollment StartAug 24, 2020
Primary CompletionDec 20, 2021
Study CompletionJan 4, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.1 years ago
Interventions
Drug-specific alertother
A drug-specific alert, informing the provider of the presence of AKI as well as recent exposure to a potentially nephrotoxic agent, will be fired.